Administration of thyroxin in midgestation has been reported to prevent
spontaneous cleft lip in term fetuses of genetically predisposed mice. Attempts to repeat
this finding have given ambiguous results. The experiment was therefore repeated using
CL/Fr and A/HeJ mice, and various thyroxin dosages. The embryos were examined on days
13 and 14, earlier in gestation than in previous studies. The usual complement of cleft-lip
embryos, 21% in CL/Fr and 10% in A/HeJ, was present, but they were often dead. At all
dosages of thyroxin that caused embryonic mortality, differential mortality of cleft-lip
embryos compared with normals, was demonstrated. The reduced frequency of cleft-lip
embryos at term after thyroxin treatment is thus due to their increased mortality, not to
prevention of the lip defect.